Japan Market Entry: The US Healthtech Startup Journey (A joint program between Japan Society and the ACCJ)

Name: Japan Market Entry: The US Healthtech Startup Journey (A joint program between Japan Society and the ACCJ)
Start: 2025-09-17T08:30:00+09:00
End: 2025-09-17T10:00:00+09:00
Location: Tokyo American Club, Manhattan Room

Sep 17 2025, 8:30 am - 10:00 am

$35

Invitation Only

Tokyo American Club, Manhattan Room

2-chōme-1-2 Azabudai
Minato-ku, Tokyo 106-8649 Japan
+ Google Map

*In-person Event in Tokyo
*Invitation Only

Breaking into Japan’s healthtech markets offers enormous potential, but also significant challenges for startups. Hear from senior executives at the forefront of their startup journey from US-based early-stage life science companies as they share why Japan is critical to their growth, their strategies for market entry, and the challenges they face.

Mark Amouzgar, CEO of March Health, and Alex Yoshikawa, Co-Founder and CSO for Adaptyx Biosciences are paving the way for healthtech startups entering Japan. Join us for their perspectives on Japan’s healthtech and life science sectors, how they have navigated market entry, and the lessons learned from their entrepreneurial journeys.

The event will be moderated by Steve Pollock, President of Japan Society of Northern California and presented in partnership with the U.S.–Japan Healthcare Connection, a healthcare-focused program initiative of the Japan Society of Northern California.

Speakers:
Mark Amouzgar is the CEO of March Health, a Series A company specializing in women’s health. The company uses an AI-powered platform and digital twins to diagnose and treat women’s health issues, including infertility, endometriosis, and other gynecologic conditions. The company was selected for Techstars Tokyo in 2024.

Alex Yoshikawa is the Co-Founder and CSO for Adaptyx Biosciences, a seed stage company founded from Tom Soh’s lab in Stanford University. The company is building a platform for continuous molecular monitoring to enable earlier intervention and improved disease management, with an initial application targeting heart failure. Adaptyx Biosciences is seeking strategic partners in Japan in the areas of advanced sensing technology, manufacturing, and clinical research.

Moderator:
Steve Pollock assumed the position of President of Japan Society of Northern California on August 23, 2022. Previously a JSNC Board member, Mr. Pollock has been actively involved with a number of the Society’s signature initiatives, including starting JSNC’s operations in Japan in 2016, leading the corporate membership committee, and serving on the steering committee for the annual Innovation Awards.

Date & Time:
Wednesday, September 17th, 2025, 8:30AM – 10:00AM JST

Venue:
Tokyo American Club, Manhattan Room | 2-chōme-1-2 Azabudai, Minato City, Tokyo 106-8649, Japan

Admission:
$35 (Special member rate for people who sign up and pay through this link)

Agenda:
8:30-8:55 AM: Breakfast Buffet & Networking
8:55-9:00 AM: Opening Remarks by Kawai-san & Speaker Introduction by Steve Pollock
9:00-9:30 AM: Speaker Presentation
9:30-9:55 AM: Q&A
9:55-10:00 AM: Closing Remarks

NOTE 1: This event is OFF THE RECORD.
NOTE 2: Please note that, as with all guest presentations, the content and comments of the speakers reflect their own opinions and do not necessarily represent the opinions or policies of the ACCJ.
NOTE 3: Registration is on a first-come, first-served basis, and spots may be filled before the registration deadline. We recommend registering early to secure your place.
NOTE 4: If you cancel after the stated deadline, the full meeting fee will be charged to your account. All guests must be accompanied by a member of the ACCJ. No substitutions or walk-ins.
NOTE 5: If you are driving to Tokyo American Club, please inform the ACCJ of the make, model, color, and plate of the vehicle by the registration deadline, as arrangements must be made. A ¥2,500 parking fee will apply.

In Collaboration with the American Chamber of Commerce in Japan

Our Amazing Speakers

Alex Yoshikawa, Ph.D. | Co-Founder & Chief Science Officer, Adaptyx Biosciences

Alex Yoshikawa, Ph.D., is the Co-Founder and Chief Science Officer of Adaptyx Biosciences. A Stanford University spin-off, Adaptyx is developing a next-generation biomonitoring platform built on over 15 years of foundational research, enabling minimally invasive, real-time, continuous sensing of small molecules and proteins.

Alex earned his Ph.D. in Chemical Engineering from Stanford University, where his work focused on high-throughput biomolecular engineering and the development of novel biosensors. Prior to founding Adaptyx, he was an early team member at biotech startups working at the forefront of nucleic acid therapeutics and cloud lab automation.

Mark Amouzgar | CEO & Co-founder, March Health

Mark Amouzgar is the CEO and Co-founder of March.Health, a pioneering healthtech company recognized by the U.S.-Japan Trade Commission for its transformative potential in women’s health.

Under his leadership, March.Health is developing the world’s most advanced digital twin platform for complex women’s health conditions—leveraging multi-modal data including genomics, clinical records, and patient-reported outcomes. This high-fidelity modeling empowers pharmaceutical and healthcare organizations to de-risk and accelerate clinical trials, identify novel biomarkers and therapeutic targets, and deliver truly personalized medicine.

With a distinguished background in artificial intelligence and large-scale data science at leading technology firms, Mark has dedicated his career to translating complex data into real-world solutions for profound human challenges. He is the holder of multiple patents and a recognized leader in AI-driven healthcare innovation.

Mark is committed to bridging technology and medicine to drive faster diagnoses, more effective treatments, and a more equitable standard of care for millions of women worldwide.

Moderator:

Steve Pollock | President, Japan Society of Northern California

Steve Pollock assumed the position of President of Japan Society of Northern California on August 23, 2022. Previously a JSNC Board member, Mr. Pollock has been actively involved with a number of the Society’s signature initiatives, including starting JSNC’s operations in Japan in 2016, leading the corporate membership committee, and serving on the steering committee for the annual Innovation Awards.